about
Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based studyESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†Radiotherapy in patients with distant metastatic breast cancer.Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases.Surgical resection of a liver metastasis from breast cancerDEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases.Management of primary metastatic breast cancer in elderly patients--an international comparison of oncogeriatric versus standard care.Progesterone regulates the proliferation of breast cancer cells - in vitro evidence.Pathways to breast cancer recurrence.β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastasesPrimary surgical treatment of locally advanced breast cancer in low resource settings.Primary 4T1 tumor resection provides critical "window of opportunity" for immunotherapy.Liver resection for HER2-enriched breast cancer metastasis: case report and review of the literature.A multicenter, phase II study of epirubicin/cyclophosphamide followed by docetaxel and concurrent trastuzumab as primary systemic therapy for HER-2 positive advanced breast cancer (the HER2NAT study).Liver resection in selected patients with metastatic breast cancer: a single-centre analysis and review of literature.Thyroid metastasectomy.Is Stereotactic Body Radiotherapy (SBRT) in lymph node oligometastatic patients feasible and effective?The impact of local treatment of the primary tumor site in node positive and metastatic prostate cancer patients.First site of recurrence after breast cancer adjuvant treatment in the era of multimodality therapy: which imaging for which patient during follow-up?Selecting patients for gastrectomy in metastatic esophago-gastric cancer: clinics and pathology are not enough.Costs and effects of intra-operative fluorescence molecular imaging - A model-based, early assessment.Could local surgery improve survival in de novo stage IV breast cancer?
P2860
Q29248323-691F784A-7BF8-49B4-B12B-2A5F02C09955Q30317067-EEDD865B-3C13-4FD9-B4CE-E5AA94C309ABQ33759443-07714318-6F01-4A41-88F4-FC53806412BEQ33823590-D54D7649-2A44-46B1-A12B-ED5AA06472D4Q35758296-F5913DA5-9C32-4605-9171-CB14CD89018DQ35894515-DE1184F8-0669-47EA-A003-72797271C7D9Q36198921-C5177CC5-52D3-4802-8F8F-F8DC227E283FQ36277982-B5B1582C-8A7E-4D7B-AA75-198BE90F681AQ36702139-2CA33195-C754-4A10-8A51-FC21D14FCA50Q36706395-0A73A437-8DF7-49A1-9A21-8B6401D0429BQ37386094-B005799C-853A-4139-BFE8-D2474BD9EC5EQ37625349-CB065FA2-7B3F-49CA-A9C2-283F064E2CD5Q37653376-DAB79C74-BD41-4EA9-BC01-D628104C3884Q38029563-86648AB8-8F33-4C7E-BE4B-9ACA2736A92DQ38104240-2DD9621D-991A-4516-A336-376C45A45678Q38152342-53588B06-895D-4E4E-93B8-481BFC366539Q38677028-C770651C-E556-42A2-8F40-F68C542611C9Q38990182-7DB16EDC-134A-4242-8FF9-941E5DF15265Q46896796-45F08057-6E35-4B19-99AF-DF143B1493BEQ47915753-8AD55DF1-60E6-4F94-8947-634BFE51C81BQ55111538-8F4D8D6A-61D6-4CCE-A323-62475936B9D5Q58752612-FEE2261C-0C22-4A8E-81E6-32D73085727B
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The role of surgery in metastatic breast cancer.
@en
The role of surgery in metastatic breast cancer.
@nl
type
label
The role of surgery in metastatic breast cancer.
@en
The role of surgery in metastatic breast cancer.
@nl
prefLabel
The role of surgery in metastatic breast cancer.
@en
The role of surgery in metastatic breast cancer.
@nl
P1476
The role of surgery in metastatic breast cancer.
@en
P2093
Jetske Ruiterkamp
Miranda F Ernst
P356
10.1016/S0959-8049(11)70142-3
P478
47 Suppl 3
P577
2011-09-01T00:00:00Z